Gene · 5518
Papers1,733
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,733
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| E3 ligase RNF145 regulates airway smooth muscle cell proliferation via the PP2A-p70S6K signaling axis. | J Biol Chem | 2026 | 42575436 | PubTator, text mining | PubMed |
| Long-read, whole-genome sequencing and chemotherapy response of two patient-derived organoids from a TP53- and KRAS-mutant ovarian carcinoma. | bioRxiv | 2026 | 42465424 | PubTator, text mining | PubMed |
| SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress. | Cell Mol Life Sci | 2026 | 42440147 | PubTator, text mining | PubMed |
| The role of PPP2R1A variants in gynecologic malignancies: a paradigm shift in immuno-oncology. | J Transl Med | 2026 | 42063097 | PubTator, text mining | PubMed |
| Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence. | NPJ Precis Oncol | 2026 | 41872329 | PubTator, text mining | PubMed |
| Phosphoethanolamine cytidylyltransferase 2 exerts an anti-tumor role in clear cell renal cell carcinoma by modulating the hippo/YAP1 signaling pathway in a PPP2R1A-dependent manner. | Toxicol Appl Pharmacol | 2026 | 41802576 | PubTator, text mining | PubMed |
| Transcriptional control of PPP2CB by YAP1 and TEAD1 mediates AMPK inhibition and mTORC1 activation in vascular smooth muscle cells. | iScience | 2026 | 41797917 | PubTator, text mining | PubMed |
| Succinylation: novel molecular mechanisms and prospects for targeted therapy in liver diseases. | Front Mol Biosci | 2026 | 41788628 | PubTator, text mining | PubMed |
| Comprehensive Genomic Profiling Across Diverse Solid Tumors: A Real-World Experience From India With FoundationOne®CDx Testing. | Cureus | 2026 | 41717185 | PubTator, text mining | PubMed |
| Molecular Landscape of Advanced Endometrial Cancer: Exploratory Analyses at Modena Cancer Center (MEMO). | Int J Mol Sci | 2026 | 41596744 | PubTator, text mining | PubMed |
| PP2A dysfunction mediated by PPP2R1A deficiency drives cGAS-STING-dependent hyperinflammation in SLE CD14+ monocytes. | Clin Rheumatol | 2026 | 41582267 | PubTator, text mining | PubMed |
| Investigating the molecular mechanisms of glutamine metabolism and mitochondria-related biomarkers in Alzheimer's disease through transcriptomics and experimental validation. | Eur J Med Res | 2026 | 41540481 | PubTator, text mining | PubMed |
| GXYLT2 serves as a prognostic biomarker and is associated with β-catenin activation and gastric cancer aggressiveness. | Genes Dis | 2026 | 41492474 | PubTator, text mining | PubMed |
| Sodium butyrate ameliorates renal tubular lipid accumulation through a protein phosphatase 2A/transcription factor EB axis in diabetic nephropathy. | Br J Pharmacol | 2026 | 41337753 | PubTator, text mining | PubMed |
| Clinical and Molecular Spectrum of PPP2R1A-Related Neurodevelopmental Disorders: A Systematic Review. | Genes (Basel) | 2025 | 41465181 | PubTator, text mining | PubMed |
| Expression characteristics, prognostic value, and immune-related analysis of PPP2R1A in lung adenocarcinoma. | Front Immunol | 2025 | 41409293 | PubTator, text mining | PubMed |
| Phosphatase PP2A promotes RTA dephosphorylation to impair KSHV lytic replication. | PLoS Pathog | 2025 | 41337097 | PubTator, text mining | PubMed |
| Determining potential therapeutic targets for venous thrombosis through network pharmacology, cluster typing, WGCNA, machine learning, immune infiltration analysis, and ceRNA networks. | Medicine (Baltimore) | 2025 | 41327671 | PubTator, text mining | PubMed |
| Discovery of a bifunctional PKMYT1-targeting PROTAC empowered by AI-generation. | Nat Commun | 2025 | 41315240 | PubTator, text mining | PubMed |
| PPP2R1A Mutation: A Critical Amplifier for Immune Checkpoint Blockade Therapy Efficacy. | MedComm (2020) | 2025 | 41281191 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5518/papers